Sotera Health Company (MUN:SH5)
Germany
· Delayed Price · Currency is EUR | Market Cap | 3.91B |
| Revenue (ttm) | 991.05M |
| Net Income (ttm) | 66.39M |
| Shares Out | n/a |
| EPS (ttm) | 0.23 |
| PE Ratio | 58.91 |
| Forward PE | 16.62 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | n/a |
| Average Volume | 8 |
| Open | 13.60 |
| Previous Close | 14.10 |
| Day's Range | 13.60 - 13.60 |
| 52-Week Range | 8.60 - 16.70 |
| Beta | n/a |
| RSI | 34.74 |
| Earnings Date | Feb 24, 2026 |
About Sotera Health Company
Sotera Health Company provides sterilization solutions, lab testing, and advisory services for the healthcare industry in the United States, Canada, Europe, and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. The Sterigenics segment offers outsourced terminal sterilization and irradiation services using gamma irradiation, ethylene oxide processing, and electron beam irradiation technologies for medical devices, pharmaceutical, and food safety and advanced applications markets. The Nordion seg... [Read more]
Financial Performance
In 2025, Sotera Health Company's revenue was $1.16 billion, an increase of 5.74% compared to the previous year's $1.10 billion. Earnings were $77.95 million, an increase of 75.79%.
Financial numbers in USD Financial StatementsNews
Sotera Health Company (SHC) Q4 2025 Earnings Call Transcript
Sotera Health Company (SHC) Q4 2025 Earnings Call Transcript
Sotera Health Delivers 20th Consecutive Year of Revenue Growth and Provides 2026 Outlook
2025 net revenues increased 5.7% to $1.164 billion , compared to 2024, or 5.2% on a constant currency basis 2025 net income increased to $78 million or $0.27 per diluted share, compared to net income ...
Sotera Health Announces Fourth-Quarter and Full-Year 2025 Earnings Release Date
CLEVELAND, Feb. 17, 2026 (GLOBE NEWSWIRE) -- Sotera Health Company (Nasdaq: SHC), a leading global provider of mission-critical end-to-end sterilization solutions, lab testing and advisory services fo...
Sotera Health Appoints Richard Kyle to the Board of Directors
CLEVELAND, Feb. 05, 2026 (GLOBE NEWSWIRE) -- Sotera Health Company (Nasdaq: SHC), a leading global provider of mission-critical end-to-end sterilization solutions, lab testing and advisory services fo...
Sotera Health Company (SHC) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Sotera Health Company (SHC) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Sotera Health to Showcase Continued Revenue Growth and Strategic Value Creation at 44th Annual J.P. Morgan Healthcare Conference
CLEVELAND, Jan. 12, 2026 (GLOBE NEWSWIRE) -- Sotera Health Company (“Sotera Health” or the “Company”) (Nasdaq: SHC), a leading global provider of mission-critical end-to-end sterilization solutions, l...
Sotera Health to Present at the 44th Annual J.P. Morgan Healthcare Conference
CLEVELAND, Jan. 07, 2026 (GLOBE NEWSWIRE) -- Sotera Health Company (“Sotera Health” or the “Company”) (NASDAQ: SHC), a leading global provider of mission-critical end-to-end sterilization solutions, l...
Sotera Health Announces Secondary Offering of Common Stock
CLEVELAND, Nov. 06, 2025 (GLOBE NEWSWIRE) -- Sotera Health Company (Nasdaq: SHC) (the “Company”) today announced the launch of a secondary offering (the “Offering”) of 30,000,000 shares of its common ...
Sotera Health Company (SHC) Q3 2025 Earnings Call Transcript
Sotera Health Company ( SHC) Q3 2025 Earnings Call November 4, 2025 9:00 AM EST Company Participants Jason Peterson - VP & Treasurer Michael Petras - Chairman & CEO Jonathan Lyons - Senior VP & CFO C...
Sotera Health Reports Strong Third-Quarter and Year-to-Date 2025 Results
Q3 2025 net revenues increased 9.1% to $311 million , or 8.0% on a constant currency basis ( 1) , compared to Q3 2024 Q3 2025 net income of $48 million, or $0.17 per diluted share, compared to net in...
Sotera Health Announces Third-Quarter 2025 Earnings Release Date
CLEVELAND, Oct. 21, 2025 (GLOBE NEWSWIRE) -- Sotera Health Company (Nasdaq: SHC), a leading global provider of mission-critical end-to-end sterilization solutions, lab testing and advisory services fo...
Sotera Health Company (SHC) Q2 2025 Earnings Call Transcript
Sotera Health Company (NASDAQ:SHC) Q2 2025 Earnings Conference Call August 8, 2025 9:00 AM ET Company Participants Jason Peterson - VP & Treasurer Jonathan M. Lyons - Senior VP & CFO Michael B.
Sotera Health Reports Strong Second-Quarter and First-Half 2025 Results
CLEVELAND, Aug. 08, 2025 (GLOBE NEWSWIRE) -- Sotera Health Company (“Sotera Health” or the “Company”) (Nasdaq: SHC), a leading global provider of mission-critical end-to-end sterilization solutions, l...
Sotera Health Announces Second-Quarter 2025 Earnings Release Date
CLEVELAND, July 28, 2025 (GLOBE NEWSWIRE) -- Sotera Health Company (Nasdaq: SHC), a leading global provider of mission-critical end-to-end sterilization solutions and lab testing and advisory services...
Trends Shaping Qatar's Infection Control Market 2025-2034: Featuring Sidra Medicine, BD, Condair, Sotera Health, Olympus, 3M
The Qatar infection control market is driven by automated and AI-powered sterilization systems. Rising hospital admissions, awareness of healthcare-associated infections, and advanced disinfection tec...
Sotera Health Company (SHC) Q1 2025 Earnings Call Transcript
Sotera Health Company (NASDAQ:SHC) Q1 2025 Earnings Conference Call May 1, 2025 9:00 AM ET Company Participants Michael Petras - Chairman, Chief Executive Officer Jonathan Lyons - Chief Financial Off...
Sotera Health Reports First-Quarter 2025 Results
CLEVELAND, May 01, 2025 (GLOBE NEWSWIRE) -- Sotera Health Company (“Sotera Health” or the “Company”) (Nasdaq: SHC), a leading global provider of mission-critical end-to-end sterilization solutions, la...
Sotera Health Announces First-Quarter 2025 Earnings Release Date
CLEVELAND, April 17, 2025 (GLOBE NEWSWIRE) -- Sotera Health Company (Nasdaq: SHC), a leading global provider of mission-critical end-to-end sterilization solutions and lab testing and advisory service...
Sotera Health Has A Great Deleveraging Path Ahead
Sotera Health offers essential sterilization, lab testing, and advisory services, ensuring safety and regulatory compliance for medical, pharmaceutical, and food products, with high customer retention...
Nelson Labs Launches Innovative Rapid Sterility Testing to Significantly Expedite Product Sterility Results
Rapid Sterility Testing yields product sterility test results in as little as 6 days and can be used for broadscale medical device and pharmaceutical product application Rapid Sterility Testing yields...
Sotera Health Company (SHC) Q4 2024 Earnings Call Transcript
Sotera Health Company (NASDAQ:SHC) Q4 2024 Earnings Conference Call February 27, 2025 9:00 AM ET Company Participants Jason Peterson – Vice President of Investor Relations and Treasurer Michael Petra...
Sotera Health Reports Fourth-Quarter and Full-Year 2024 Results; Provides 2025 Outlook
CLEVELAND, Feb. 27, 2025 (GLOBE NEWSWIRE) -- Sotera Health Company (“Sotera Health” or the “Company”) (Nasdaq: SHC), a leading global provider of mission-critical end-to-end sterilization solutions, l...
Sotera Health Announces Fourth-Quarter and Full-Year 2024 Earnings Release Date
CLEVELAND, Feb. 18, 2025 (GLOBE NEWSWIRE) -- Sotera Health Company (Nasdaq: SHC), a leading global provider of mission-critical end-to-end sterilization solutions and lab testing and advisory services...
Sotera Health Chairman and CEO Presents at 43rd Annual J.P. Morgan Healthcare Conference
CLEVELAND, Jan. 14, 2025 (GLOBE NEWSWIRE) -- Sotera Health Company (“Sotera Health” or the “Company”) (Nasdaq: SHC), a leading global provider of mission-critical end-to-end sterilization solutions an...
Sotera Health to Present at the 43rd Annual J.P. Morgan Healthcare Conference
CLEVELAND, Jan. 07, 2025 (GLOBE NEWSWIRE) -- Sotera Health Company (“Sotera Health” or the “Company”) (NASDAQ: SHC), a leading global provider of mission-critical end-to-end sterilization solutions, l...